Robust, Futureproof, IP Protection in Biotech

Protecting Biotech Innovations: A Robust and Future-Proof IP Solution

In biotech, intellectual property is built on experimental data. But proving the integrity of that data—especially years after it was created—can be a significant challenge.

This case study explores how leading biotech organizations use ZONTAL to ensure that experimental records remain complete, traceable, and legally defensible over time.

Table of Contents

The Challenge

Scientific data must often serve as legal evidence in patent disputes that arise many years after the original experiments were performed. To be admissible, organizations must demonstrate that their records have not been altered and can be trusted.

While electronic lab notebooks have replaced paper, most do not provide consistent mechanisms for digital signatures or long-term integrity across multiple systems. In environments where several ELNs are in use, experimental data becomes fragmented, making it difficult to guarantee authenticity and completeness.

The Solution

ZONTAL enables organizations to capture and preserve experimental data as complete, verifiable information packages.

Data from multiple ELN systems and instruments is automatically consolidated into a single record that includes raw data, associated files, and a digitally signed version designed for long-term readability. Each package is enriched with metadata and integrity checks, ensuring that the full context of the experiment is preserved.

This creates a clear, traceable link back to the point of invention—supporting both scientific and legal requirements.

The Outcome

With ZONTAL, organizations move from fragmented and manual processes to a fully connected and automated workflow.

Experimental data can be easily searched, retrieved, and validated through a centralized system, allowing teams to quickly access the information they need. At the same time, digital signatures and audit trails ensure that records remain secure and defensible.

The result is stronger IP protection, improved operational efficiency, and greater confidence that critical data will stand up to legal scrutiny when it matters most.

Why It Matters

IP protection is not just about storing data—it is about preserving trust.

By ensuring that experimental records remain complete, authentic, and traceable over time, ZONTAL helps biotech organizations protect their most valuable assets while maintaining compliance across the R&D lifecycle.

Explore the Full Case study